40 related articles for article (PubMed ID: 31966448)
21. Bone morphogenetic protein-9 inhibits lymphatic vessel formation via activin receptor-like kinase 1 during development and cancer progression.
Yoshimatsu Y; Lee YG; Akatsu Y; Taguchi L; Suzuki HI; Cunha SI; Maruyama K; Suzuki Y; Yamazaki T; Katsura A; Oh SP; Zimmers TA; Lee SJ; Pietras K; Koh GY; Miyazono K; Watabe T
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18940-5. PubMed ID: 24133138
[TBL] [Abstract][Full Text] [Related]
22. [WHO classification of tumors of the breast, 2012].
Frank GA; Danilova NV; Andreeva IuIu; Nefedova NA
Arkh Patol; 2013; 75(2):53-63. PubMed ID: 24006766
[TBL] [Abstract][Full Text] [Related]
23. BMP9 is a proliferative and survival factor for human hepatocellular carcinoma cells.
Herrera B; García-Álvaro M; Cruz S; Walsh P; Fernández M; Roncero C; Fabregat I; Sánchez A; Inman GJ
PLoS One; 2013; 8(7):e69535. PubMed ID: 23936038
[TBL] [Abstract][Full Text] [Related]
24. Bone morphogenetic protein 9 overexpression reduces osteosarcoma cell migration and invasion.
Lv Z; Yang D; Li J; Hu M; Luo M; Zhan X; Song P; Liu C; Bai H; Li B; Yang Y; Chen Y; Shi Q; Weng Y
Mol Cells; 2013 Aug; 36(2):119-26. PubMed ID: 23807047
[TBL] [Abstract][Full Text] [Related]
25. BMP9 signaling in stem cell differentiation and osteogenesis.
Lamplot JD; Qin J; Nan G; Wang J; Liu X; Yin L; Tomal J; Li R; Shui W; Zhang H; Kim SH; Zhang W; Zhang J; Kong Y; Denduluri S; Rogers MR; Pratt A; Haydon RC; Luu HH; Angeles J; Shi LL; He TC
Am J Stem Cells; 2013; 2(1):1-21. PubMed ID: 23671813
[TBL] [Abstract][Full Text] [Related]
26. Bone morphogenetic protein-9 induces epithelial to mesenchymal transition in hepatocellular carcinoma cells.
Li Q; Gu X; Weng H; Ghafoory S; Liu Y; Feng T; Dzieran J; Li L; Ilkavets I; Kruithof-de Julio M; Munker S; Marx A; Piiper A; Augusto Alonso E; Gretz N; Gao C; Wölfl S; Dooley S; Breitkopf-Heinlein K
Cancer Sci; 2013 Mar; 104(3):398-408. PubMed ID: 23281849
[TBL] [Abstract][Full Text] [Related]
27. New targets and approaches in osteosarcoma.
Gill J; Ahluwalia MK; Geller D; Gorlick R
Pharmacol Ther; 2013 Jan; 137(1):89-99. PubMed ID: 22983152
[TBL] [Abstract][Full Text] [Related]
28. BMP9 inhibits the proliferation and invasiveness of breast cancer cells MDA-MB-231.
Wang K; Feng H; Ren W; Sun X; Luo J; Tang M; Zhou L; Weng Y; He TC; Zhang Y
J Cancer Res Clin Oncol; 2011 Nov; 137(11):1687-96. PubMed ID: 21892652
[TBL] [Abstract][Full Text] [Related]
29. BMP-9 induced osteogenic differentiation of mesenchymal stem cells: molecular mechanism and therapeutic potential.
Luther G; Wagner ER; Zhu G; Kang Q; Luo Q; Lamplot J; Bi Y; Luo X; Luo J; Teven C; Shi Q; Kim SH; Gao JL; Huang E; Yang K; Rames R; Liu X; Li M; Hu N; Liu H; Su Y; Chen L; He BC; Zuo GW; Deng ZL; Reid RR; Luu HH; Haydon RC; He TC
Curr Gene Ther; 2011 Jun; 11(3):229-40. PubMed ID: 21453282
[TBL] [Abstract][Full Text] [Related]
30. Targets for cancer therapy in childhood sarcomas.
Wachtel M; Schäfer BW
Cancer Treat Rev; 2010 Jun; 36(4):318-27. PubMed ID: 20223596
[TBL] [Abstract][Full Text] [Related]
31. Osteosarcoma: the COSS experience.
Bielack S; Jürgens H; Jundt G; Kevric M; Kühne T; Reichardt P; Zoubek A; Werner M; Winkelmann W; Kotz R
Cancer Treat Res; 2009; 152():289-308. PubMed ID: 20213397
[TBL] [Abstract][Full Text] [Related]
32. Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4.
Ye L; Kynaston H; Jiang WG
Mol Cancer Res; 2008 Oct; 6(10):1594-606. PubMed ID: 18922975
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery.
Kang Q; Sun MH; Cheng H; Peng Y; Montag AG; Deyrup AT; Jiang W; Luu HH; Luo J; Szatkowski JP; Vanichakarn P; Park JY; Li Y; Haydon RC; He TC
Gene Ther; 2004 Sep; 11(17):1312-20. PubMed ID: 15269709
[TBL] [Abstract][Full Text] [Related]
34. The TNM staging system and breast cancer.
Benson JR; Weaver DL; Mittra I; Hayashi M
Lancet Oncol; 2003 Jan; 4(1):56-60. PubMed ID: 12517540
[No Abstract] [Full Text] [Related]
35. Consequences of knocking out BMP signaling in the mouse.
Zhao GQ
Genesis; 2003 Jan; 35(1):43-56. PubMed ID: 12481298
[TBL] [Abstract][Full Text] [Related]
36. Bone morphogenetic proteins: multifunctional regulators of vertebrate development.
Hogan BL
Genes Dev; 1996 Jul; 10(13):1580-94. PubMed ID: 8682290
[No Abstract] [Full Text] [Related]
37. Novel regulators of bone formation: molecular clones and activities.
Wozney JM; Rosen V; Celeste AJ; Mitsock LM; Whitters MJ; Kriz RW; Hewick RM; Wang EA
Science; 1988 Dec; 242(4885):1528-34. PubMed ID: 3201241
[TBL] [Abstract][Full Text] [Related]
38. The potential regulatory role of BMP9 in inflammatory responses.
Song T; Huang D; Song D
Genes Dis; 2022 Nov; 9(6):1566-1578. PubMed ID: 36157503
[TBL] [Abstract][Full Text] [Related]
39. Bone morphogenetic protein 9 is a potential tumor suppressor in osteosarcoma.
Liang J; Zhang J; Chen F; Lian Z; Dong Y; Lu N; Jia Y
Int J Clin Exp Pathol; 2017; 10(11):11030-11036. PubMed ID: 31966448
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
